V. Breder, L. G. Zhukova, L. V. Bolotina, I.A. Demidova, Y. A. Zhulikov, E. Lubennikova, D. Naskhletashvili, Sergey Orlov, R. V. Orlova, Ilya S. Romanov, Nikita A. Savelov, K. A. Sarantseva, A. Tyulyandina, M. Fedyanin
{"title":"咨询委员会关于以下主题的决议\"恩替替尼在治疗 NTRK 融合阳性实体瘤成年患者中的地位","authors":"V. Breder, L. G. Zhukova, L. V. Bolotina, I.A. Demidova, Y. A. Zhulikov, E. Lubennikova, D. Naskhletashvili, Sergey Orlov, R. V. Orlova, Ilya S. Romanov, Nikita A. Savelov, K. A. Sarantseva, A. Tyulyandina, M. Fedyanin","doi":"10.26442/18151434.2023.3.202441","DOIUrl":null,"url":null,"abstract":"NTRK-fusion positive tumors are a rare finding, but targeted therapy demonstrates persistent and sustained systemic and intracranial responses to entrectinib. This resolution proposes algorithms for diagnosing NTRK translocations in various solid tumors and discuses clinical data on the efficacy and safety of entrectinib.","PeriodicalId":16401,"journal":{"name":"Journal of Modern Oncology","volume":"54 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”\",\"authors\":\"V. Breder, L. G. Zhukova, L. V. Bolotina, I.A. Demidova, Y. A. Zhulikov, E. Lubennikova, D. Naskhletashvili, Sergey Orlov, R. V. Orlova, Ilya S. Romanov, Nikita A. Savelov, K. A. Sarantseva, A. Tyulyandina, M. Fedyanin\",\"doi\":\"10.26442/18151434.2023.3.202441\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"NTRK-fusion positive tumors are a rare finding, but targeted therapy demonstrates persistent and sustained systemic and intracranial responses to entrectinib. This resolution proposes algorithms for diagnosing NTRK translocations in various solid tumors and discuses clinical data on the efficacy and safety of entrectinib.\",\"PeriodicalId\":16401,\"journal\":{\"name\":\"Journal of Modern Oncology\",\"volume\":\"54 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Modern Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26442/18151434.2023.3.202441\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Modern Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26442/18151434.2023.3.202441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”
NTRK-fusion positive tumors are a rare finding, but targeted therapy demonstrates persistent and sustained systemic and intracranial responses to entrectinib. This resolution proposes algorithms for diagnosing NTRK translocations in various solid tumors and discuses clinical data on the efficacy and safety of entrectinib.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
